Skip to main content
. 2017 Aug 1;23(5):347–353. doi: 10.5152/dir.2017.160338

Table 1.

Patients, lesions, and procedures

No hemoptysis n=205 Any hemoptysis n=44 Mild hemoptysis n=24 Abundant hemoptysis n=20
Nonmodifiable parameters

Female gender 64 (31) 24 (54) 14 (58) 10 (50)

Age (years) 66.8±10.4 68.3±10.2 66.9±8.4 70.1±12.0

Lesion size (cm) 4.4±4.1 2.7±1.7 2.5±1.2 3.0±2.2

Nonperipheral location 96 (47) 26 (59) 15 (63) 11 (55)

Lower lobe location 67 (33) 20 (45) 12 (50) 8 (40)

Lesion morphology
 Cavitated 12 (6) 3 (7) 3 (12) 0
 Solid 177 (87) 39 (89) 21 (88) 18 (90)
 Subsolid 5 (2) 1 (2) 0 1 (5)
 Necrotic 11 (5) 1 (2) 0 1 (5)

Lesion attenuation (Hounsfield units) 37.2±19.9 39.3±25.5 32.5±19.6 49.4 (30)

Histologic type
 Adenocarcinoma 76 (37) 22 (50) 11 (46) 11 (55)
 Squamous cell carcinoma 29 (14) 4 (9) 2 (8) 2 (10)
 Metastasis 23 (11) 5 (11) 4 (17) 1 (5)
 Other tumor 39 (19) 7 (16) 3 (12) 4 (20)
 Nontumoral 38 (19) 6 (14) 4 (17) 2 (10)

Modifiable parameters
Patient position
 Prone 78 (38) 16 (36) 9 (37) 7 (35)
 Supine 86 (42) 19 (43) 10 (42) 9 (45)
 Contralateral decubitus 41 (20) 9 (20) 5 (21) 4 (20)

Ipsilateral decubitus 23 (11) 6 (14) 4 (17) 2 (10)

Transpulmonary needle-path length (cm) 1.5±1.6 2.5±1.9 2.4±1.9 2.5±1.9

Coaxial tip outside the target lesion 31 (15) 10 (23) 2 (8) 8 (40)

Lesion diameter along the needle path (cm) 2.3±1.7 1.7 ±1.3 1.6±0.8 1.9 ±1.7

 <2.2 cm 119 (58) 34 (77) 18 (75) 16 (80)

Operator:
 Operator 1 141 (69) 29 (66) 16 (67) 13 (66)
 Operator 2 64 (31) 15 (34) 8 (33) 7 (34)

Number of per-procedure CT acquisitions until biopsy 2.0±1.3 2.7±1.8 2.5±1.7 3.0±1.9

Number of tissue sampling 2.9±1.0 2.5±1.1 2.6±1.6 2.3±1.0

Data are presented as n (%) or mean ± standard deviation.